LTS Corp is the US-based subsidiary of Lohmann Therapie Systeme whose headquarters are in Andernach, Germany.  LTS’s research and development focuses on two new technologies to complement and expand the potential of alternative drug delivery systems. In addition to the development of LTS Transdermal and LTS Oral Thin Film technologies, the company also develops innovative microneedle and the ‘active LTS Transdermal’ technology.

LTS Microneedles that are long enough to penetrate the outer layer of skin but too short to irritate nerves and blood vessels. They can be used to inject active substances with larger molecules into the skin, an application that is largely pain-free. Microneedles create tiny holes in the outermost layer of skin, which significantly increases the rate at which the active substance is absorbed. 
LTS is currently researching a number of different microneedles made from different materials and with different gauges, designs and sizes for a wide range of applications.

Biotechnology

Life Sciences

Medical Devices

LTS - Lohmann Therapy Systems

David Doles

Rolf Pracht

Sandra Wiedersberg

Paul Pollio

Mary Boehner

Joseph Lepore

Ariel Santos

Michael Santomieri

The Quality Assurance Team at LTS - Lohmann Therapy Systems is responsible for ensuring that all products meet stringent quality and regulatory standards throughout the development and production processes. They conduct audits, manage documentation, and oversee compliance with industry regulations to guarantee the safety and efficacy of innovative drug delivery technologies, including microneedles and transdermal systems. By implementing robust quality control measures, the team plays a crucial role in advancing LTS’s commitment to delivering high-quality therapeutic solutions.

Quality Assurance Team

Engineering Team

Finance and Accounting Team

Quality Assurance Team

About

Team members

Other teams at LTS - Lohmann Therapy Systems

Engineering Team

Finance and Accounting Team